CNMD - CONMED Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
Total revenue
932,675
859,634
796,392
763,520
Cost of revenue
417,280
390,524
365,351
355,190
Gross profit
515,395
469,110
431,041
408,330
Operating expenses
Research development
43,737
42,188
32,307
32,254
Selling general and administrative
394,601
355,617
351,799
338,400
Total operating expenses
438,338
397,805
384,106
370,654
Operating income or loss
77,057
71,305
46,935
37,676
Interest expense
37,911
20,652
18,203
15,359
Total other income/expenses net
-
-
-
-2,942
Income before tax
34,279
50,653
28,732
19,375
Income tax expense
4,940
9,799
-26,755
4,711
Income from continuing operations
29,339
40,854
55,487
14,664
Net income
29,339
40,854
55,487
14,664
Net income available to common shareholders
29,339
40,854
55,487
14,664
Reported EPS
Basic
-
1.45
1.99
0.53
Diluted
-
1.41
1.97
0.52
Weighted average shares outstanding
Basic
-
28,118
27,939
27,804
Diluted
-
28,890
28,171
27,964
EBITDA
-
71,305
46,935
90,043